TYLOSIN/ANAFASIS 200MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
TYLOSIN/ANAFASIS 200MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Tylosin tartrate
Product identification
Medicine name:
TYLOSIN/ANAFASIS 200MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Tylosin tartrate
Target species:
-
Cattle
-
Sheep
-
Pig
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Tylosin tartrate200.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal21day
-
Milk5day
-
-
Sheep
-
Meat and offal42day
-
Milk108hour
-
-
Pig
-
Meat and offal21day
-
-
Dog
-
Not applicableno withdrawal period
-
-
Cat
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 55111/15-06-2021/K-0083801
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet